Insulet Corp (PODD)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$318.27

Buy

$321.38

arrow-down$-4.03 (-1.25%)

Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
Prices updated at 04 Jun 2025, 14:15 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up0.32%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
464m564m738m904m1,099m1,305m1,697m2,072m
277m370m480m582m752m806m1,160m1,446m
-7m27m50m52m126m38m220m309m
-1.604.866.775.6911.472.8812.9614.91
-27m3m12m7m17m5m206m418m
6m47m74m110m140m109m324m424m
Sales, General and administrative209m248m298m384m466m588m735m917m
Interest expenses19m26m32m45m62m36m36m43m
Provision for income taxes200,0002m3m3m4m5m8m-118m
Operating expenses285m343m430m531m626m768m940m1,137m
Income before taxes-27m5m15m10m21m10m215m300m
Net income available to common shareholders-27m3m12m7m17m5m206m418m
-0.460.060.190.110.250.072.965.97
Net interest income-19m-21m-28m-45m-61m-27m-8m-3m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)-0.460.050.190.10.240.072.945.78
Free cash flow per share-0.1946-2.2118-1.1684-0.227-2.9639-0.898-0.212.8552
Book value/share1.27323.3442.4029.01287.19736.15738.690115.9268
Debt equity ratio3.5717092.79113611.6982871.7291252.2448322.8847611.8648831.069742

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets537m461m591m1,249m1,330m1,314m1,583m1,891m
Current liabilities86m116m158m208m229m365m451m528m
Total capital725m804m964m1,647m1,805m1,851m2,099m2,508m
Total debt566m592m888m1,059m1,274m1,402m1,416m1,392m
Total equity159m212m76m604m556m476m733m1,212m
Total non current liabilities--------
Loans566m592m888m1,044m1,249m1,374m1,366m1,296m
Total assets817m929m1,143m1,873m2,049m2,251m2,588m3,088m
Total liabilities--------
Cash and cash equivalents273m114m214m907m792m674m704m953m
Common stock58m59m63m66m69m70m70m70m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period137m273m114m214m922m806m690m704m
Cash dividends paid--------
-36m-126m-72m-82m-191m-38m37m296m
Investments (gains) losses-211m-185m-74m14m-83m-191m-119m-146m
273m114m214m922m806m690m704m953m
Net income--------
41m36m98m84m-68m119m146m430m
-77m-162m-171m-166m-123m-157m-109m-134m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.